High income vs Saint Lucia: Immunization, Hib3
High income
93.2%
in 2024
Saint Lucia
99.0%
in 2024
High income rank
4th
Saint Lucia rank
1st
Immunization, Hib3 over time
- High income
- Saint Lucia
How they compare
Saint Lucia currently reports 99.0% against 93.2% in High income, a difference of 5.8%.
That makes Saint Lucia's figure about 1.1 times High income's.
The two have swapped places 5 times across 23 shared years of data; in 2002 it was High income ahead.
High income ranks 4th and Saint Lucia ranks 1st of 43 groups.
Across the 3 decades both report, High income averaged higher in 1 and Saint Lucia in 2.
Head to head by decade
| Decade | High income | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.8% | 82.4% | 12.5% | Saint Lucia |
| 2010s | 80.7% | 95.3% | 14.6% | Saint Lucia |
| 2020s | 89.1% | 84.0% | 5.1% | High income |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, High income or Saint Lucia?
- Saint Lucia, at 99.0% against 93.2% in High income as of 2024.
- What is the difference in immunization, hib3 between High income and Saint Lucia?
- 5.8%, with Saint Lucia ahead.
- How many years of comparable data are there for High income and Saint Lucia?
- 23 years are reported by both, from 2002 to 2024.
- How do High income and Saint Lucia rank globally for immunization, hib3?
- High income ranks 4th and Saint Lucia ranks 1st of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.